Adaptive Biotechnologies (ADPT) Enterprise Value (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Enterprise Value of -$210.4 million for Q1 2026, up 4.68% sequentially from -$220.8 million in Q4 2025, and down 8.68% YoY from -$230.4 million in Q1 2025.
Adaptive Biotechnologies (ADPT) Enterprise Value (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Enterprise Value data on file, last reported at -$210.4 million in Q1 2026.
- Quarterly Enterprise Value fell 8.68% year-over-year to -$210.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$210.4 million (down 8.68% YoY) and the FY2025 annual result came in at -$220.8 million, up 0.78% from the prior year.
- Enterprise Value rose to -$210.4 million in Q1 2026 per ADPT's latest filing, from -$220.8 million in the prior quarter.
- The five-year high for Enterprise Value was -$193.6 million in Q1 2025, with the low at -$508.1 million in Q3 2022.
- Average Enterprise Value over 5 years is -$319.6 million, with a median of -$309.0 million recorded in 2024.
- The widest YoY moves for Enterprise Value: up 49.1% in 2022, down 41.17% in 2022.
- Adaptive Biotechnologies' Enterprise Value stood at -$498.3 million in 2022, then soared by 30.45% to -$346.5 million in 2023, then soared by 35.79% to -$222.5 million in 2024, then increased by 0.78% to -$220.8 million in 2025, then advanced by 4.68% to -$210.4 million in 2026.
- Business Quant data shows ADPT's Enterprise Value at -$210.4 million in Q1 2026, -$220.8 million in Q4 2025, and -$213.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -462.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -3.25 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -5.69 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -200.53 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -1.10 Bn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -1.81 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -1.98 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -1.16 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -60.60 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -210.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210.43 Mn |
| Dec 31, 2025 | -220.77 Mn |
| Sep 30, 2025 | -212.95 Mn |
| Jun 30, 2025 | -198.05 Mn |
| Mar 31, 2025 | -193.63 Mn |
| Dec 31, 2024 | -222.52 Mn |
| Sep 30, 2024 | -243.53 Mn |
| Jun 30, 2024 | -292.05 Mn |
| Mar 31, 2024 | -309.02 Mn |
| Dec 31, 2023 | -346.52 Mn |
| Sep 30, 2023 | -371.23 Mn |
| Jun 30, 2023 | -417.30 Mn |
| Mar 31, 2023 | -440.76 Mn |
| Dec 31, 2022 | -498.26 Mn |
| Sep 30, 2022 | -508.11 Mn |
| Jun 30, 2022 | -383.73 Mn |
| Mar 31, 2022 | -363.51 Mn |
| Dec 31, 2021 | -352.95 Mn |
| Sep 30, 2021 | -415.01 Mn |
| Jun 30, 2021 | -598.28 Mn |